| Patents for C07K - Peptides (3,738) |
|---|
| 07/27/2006 | WO2004106360A3 Viral vectors with improved properties |
| 07/27/2006 | US20060165650 Rantes-derived peptides with anti-hiv activity |
| 07/26/2006 | EP1682569A2 Cellular membrane protein assay |
| 07/26/2006 | EP1682568A2 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
| 07/20/2006 | WO2005016955A3 Nogo receptor antagonists |
| 07/20/2006 | US20060160802 Antibiotics; e.g N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-trifluoromethyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide; N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-methyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide |
| 07/20/2006 | US20060159699 Dengue viruses useful for vaccination against Flavivirus; Modified Vaccinia Virus Ankara (MVA); stable, can easily be produced |
| 07/20/2006 | US20060159691 Ptprk immunogenic peptide |
| 07/19/2006 | EP1680443A2 Stabilized alpha helical peptides and uses thereof |
| 07/19/2006 | EP1680442A2 Pif peptides biologic activities, site of action, and the antibody to detect pif |
| 07/19/2006 | EP1680439A2 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier |
| 07/19/2006 | CN1803839A Analogs of parathyroid hormone |
| 07/19/2006 | CN1803837A Neurotrophic growth factor |
| 07/13/2006 | WO2004092197A8 Amyloid-specific peptides and uses thereof |
| 07/13/2006 | US20060155115 Multivalent T cell receptor complexes |
| 07/13/2006 | US20060154294 Interleukin-18 binding proteins, their preparation and use |
| 07/12/2006 | EP1678198A2 Side chain deuterated amino acids and methods of use |
| 07/12/2006 | EP1678197A2 Methods and compositions for pdgf-c activation and inhibition |
| 07/12/2006 | EP1678196A1 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1) |
| 07/12/2006 | EP1677825A2 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom |
| 07/12/2006 | EP1590663A4 Immunocompromised rodents as dual color tumor models |
| 07/12/2006 | EP1534749A4 Variant integrin polypeptides and uses thereof |
| 07/12/2006 | CN1800397A Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 07/11/2006 | US7074763 Stable formulations of nerve growth factor |
| 07/11/2006 | US7074559 Comprises nucleotide sequences coding mycobacterium paratuberculosis polypeptides for immunization and prevention of mycobacterial animal infections |
| 07/06/2006 | WO2005049639A3 Compositions and methods for protein isolation |
| 07/06/2006 | WO2005010022A3 Agonist polypeptide of receptor for zot and zonulin |
| 07/06/2006 | WO2004072096A3 Peptides binding gp120 of hiv-1 |
| 07/06/2006 | US20060148022 And blood-coagulation factor VII using aminonapthalene sulfonamide-based fluorogenic substrates |
| 07/05/2006 | EP1675606A2 Peptides and compounds that bind to thrombopoietin receptors |
| 07/04/2006 | US7070784 Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues |
| 06/29/2006 | WO2005019242A8 Recombinant expression of the hag1 antimicrobial peptide: use as fusion partner for the expression of alpha helical antimicrobial peptides |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/22/2006 | US20060134739 Synthesis of proteins by cell-free protein expression |
| 06/21/2006 | EP1670507A2 Vaccine for treatment and prevention of herpes simplex virus infection |
| 06/21/2006 | CN1791612A Novel antimicrobial peptides with heparin binding activity |
| 06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
| 06/20/2006 | US7063854 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 06/15/2006 | US20060128623 Treating cutaneous microbial infections such as Propionibacterium acnes by administering a granulysin peptide that is modified to increase hydrophobicity |
| 06/15/2006 | US20060127416 Polynucleotide encoding a protein believed to be highly immunogenic, especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens. |
| 06/14/2006 | EP1667982A2 Isoquinolinone potassium channel inhibitors |
| 06/14/2006 | EP1667973A2 Quinoline potassium channel inhibitors |
| 06/14/2006 | EP1667700A2 Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| 06/13/2006 | US7060490 having an N-terminal domain, a DNA-binding domain and a ligand-binding domain |
| 06/08/2006 | WO2005116052A3 ANTAGONISM OF TGF-β SUPERFAMILY RECEPTOR SIGNALING |
| 06/08/2006 | WO2005115097A3 Cyclic peptide antibiotics |
| 06/08/2006 | US20060122390 Boronic ester and acid compounds, synthesis and uses |
| 06/08/2006 | US20060122267 Compositions and methods for attenuating mitochondria-mediated cell injury |
| 06/08/2006 | US20060122171 5-[(1-Ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)(1H-imidazol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; antiproliferative agents; modulating cell differentiation,migration, and chemoinvasion; endothelial growth factor-modulated diseases; antiarthritic agents; graft versus host diseases |
| 06/08/2006 | US20060122121 Modified alpha-MSH peptides and derivatives thereof |
| 06/08/2006 | US20060121480 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 06/08/2006 | US20060121046 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 06/07/2006 | EP1666591A1 Cytokine that induces apoptosis |
| 06/07/2006 | EP1664341A2 Size-controlled macromolecule |
| 06/07/2006 | EP1664332A2 Kinase and phosphatase assays |
| 06/07/2006 | EP1664082A2 Kid3 and kid3 antibodies that bind thereto |
| 06/07/2006 | EP1663278A2 Epo mimetic peptides and fusion proteins |
| 06/07/2006 | CN1781947A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781946A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781945A Modified peptides as therapeutic agents |
| 06/06/2006 | US7056512 controlling and increasing muscle growth, especially in farm animals for slaughter, by administering an immunogenically effective amount ofa modified GDF-8 polypeptide |
| 06/01/2006 | WO2005058941A3 Aβ IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME |
| 06/01/2006 | US20060116327 Antimicrobial compounds |
| 05/31/2006 | EP1660686A2 Hpv cd8+ t-cell epitopes |
| 05/31/2006 | EP1660518A2 Complexes of gpcr142 and relaxin3 or insl5, and their production and use |
| 05/31/2006 | EP1660517A2 Nogo receptor antagonists |
| 05/31/2006 | EP0911342B1 Novel protein and process for producing the same |
| 05/31/2006 | CN1780640A Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 05/26/2006 | WO2006054947A1 Novel antimicrobial peptides |
| 05/26/2006 | CA2588145A1 Novel antimicrobial peptides |
| 05/25/2006 | US20060111281 Melanocortin receptor-specific |
| 05/25/2006 | US20060110437 Synthesis and self-assembly of abc triblock bola peptide |
| 05/25/2006 | US20060110394 Bind to alpha-4 integrin; asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, acute leukocyte mediated lung injury |
| 05/25/2006 | US20060110359 Cellular delivery of natriuretic peptides |
| 05/23/2006 | US7048930 Expression of core-glycosylated HCV envelope proteins in yeast |
| 05/18/2006 | WO2005035550A3 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier |
| 05/18/2006 | US20060104990 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 05/18/2006 | US20060104978 Methods and compositions for PDGF-C activation and inhibition |
| 05/17/2006 | EP1657255A1 Novel protein and method for producing the protein |
| 05/17/2006 | EP0807124B1 Monoclonal antibody against flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 05/17/2006 | CN1774232A Skin or hair binding peptides |
| 05/11/2006 | WO2005010023A3 Method for prediction of an epitope |
| 05/11/2006 | WO2004022578A3 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis |
| 05/11/2006 | US20060100134 fusion proteins; drug delivery |
| 05/11/2006 | US20060099684 Polypeptide of given sequence; inhibiting endothelial cell proliferation; restenosis, cancer, eye disorders |
| 05/11/2006 | US20060099571 Protease and peptidase-resistant proteins; Drug screening for control of cell division, apoptosis; for cancer treatment |
| 05/10/2006 | EP1654225A2 Melanin concentrating hormone receptor antagonists |
| 05/10/2006 | CN1255539C Pesticidal proteins and strains |
| 05/04/2006 | US20060094014 Nucleic acid supported protein complementation |
| 05/04/2006 | US20060093613 Soluble T cell receptor |
| 05/04/2006 | US20060093600 Antibodies to CD40 |
| 05/03/2006 | EP1651663A2 Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| 05/03/2006 | EP1651662A2 Antagonistic analogs of gh-rh (2003) |
| 05/03/2006 | CN1768142A Chimeric polypeptides and their use |
| 05/03/2006 | CN1766111A Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 04/26/2006 | EP1648929A2 Active subfragments of human histidine rich glycoprotein |
| 04/26/2006 | EP1648920A2 Car ligand-binding domain polypeptide co-crystallized with a ligand, and methods of designing ligands that modulate car activity |
| 04/26/2006 | EP1648919A2 Methods for detecting activation of t-cells by mhc binding peptides |
| 04/26/2006 | EP1648917A2 Agonist polypeptide of receptor for zot and zonulin |
| 04/26/2006 | CN1763194A 'Osteoclast-inhibitory factor' (ocif),its nucleotide sequence and methods for producing same |